Back

Direct ugmentation of cholesterol efflux capacity in AMI atients: a PKPD substudy of AEGIS-I

27 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Inflammation, diabetes and their influence on the heart Pharmacology ESC Premium Access ESC Congress 2017

About the speaker

Photo
Miss Megan Yee

Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial.
Doctor D. Shishikura (Takatsuki, JP)
Abstract Slides
Presentation thumbnail
Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy
Professor K. Komamura (Toyota, JP)
Abstract Slides
Presentation thumbnail
Metformin epigenetically regulates tissue factor expression in diabetes
Doctor M. Witkowski (Berlin, DE)
Abstract Slides
Presentation thumbnail
Effects of Tofogliflozin, an Sodium-glucose co-transporter 2 Inhibitor, on Cardiac Hypertrophy in Metabolic Model Rats
Doctor T. Kimura (Fukuyama, JP)
Abstract Slides
Presentation thumbnail
Effect of TNF-a antagonists on wave reflections: a meta-analysis.
Doctor D. Terentes-Printzios (Athens, GR)

Access the full session

Session thumbnail
Inflammation, diabetes and their influence on the heart

The Event

Event poster

ESC Congress 2017

27 August 2017 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources